Skip to content

Search

Professor Andrew Whitehouse on ABC720

Autism researcher Professor Andrew Whitehouse was on 720 ABC Perth yesterday taking questions on child health.

Study looks at fish oil as treatment for autism

The Kids Research Institute Australia research has shown nearly 50 per cent of children with autism have tried fish oil supplements, but does it actually improve symptoms?

An evening for the future of autism

Join Dr Andrew Whitehouse, head of Developmental Disorders research at The Kids, as he shares with you his vision for autism research.

App for Autism

An innovative iPad App developed in Western Australia could be the key to improved outcomes for kids with autism.

Pregnant women sought for autism study

Pregnant women who already have an autistic child are being sought for a study by the Autism Research Team at WA's The Kids for Child Health Research.

Autism research innovator shortlisted for Eureka Prize

Dr Andrew Whitehouse from Perth's Telethon Institute for Child Health Research shortlisted as a finalist for the prestigious 2012 Australian Museum Eureka Prize

Alternative Autism Therapies Under Scrutiny

A research review from The Kids for Child Health Research has cast doubt on the effectiveness of some complementary and alternative therapies for

Further evidence of testosterone link to autism

A new study from Perth's The Kids for Child Health Research has uncovered more evidence of a link between early testosterone levels and autism.

A pilot randomised controlled trial of a telehealth-delivered brief ‘Sleeping Sound Autism’ intervention for autistic children

Access to behavioural sleep intervention is beneficial for autistic children, yet many families face barriers to access associated with location and time. Preliminary evidence supports telehealth-delivered sleep intervention. However, no studies have evaluated brief telehealth sleep intervention.

Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial

Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to manage anxiety in adults with an autism diagnosis. However, their effectiveness and adverse effect profile in the autistic population are not well known. This trial aims to determine the effectiveness and cost-effectiveness of the SSRI sertraline in reducing symptoms of anxiety and improving quality of life in adults with a diagnosis of autism compared with placebo and to quantify any adverse effects.